| Views | |
|---|---|
| Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 385 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials | 1 | 3 | 10 | 30 | 21 | 14 | 30 |
| Views | |
|---|---|
| art_3A10.1186_2Fs13195-016-0189-7.pdf | 248 |
